CILIBERTO, GENNARO
 Distribuzione geografica
Continente #
NA - Nord America 6.526
AS - Asia 2.539
EU - Europa 1.912
SA - Sud America 203
AF - Africa 31
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 16
Totale 11.247
Nazione #
US - Stati Uniti d'America 6.295
SG - Singapore 1.811
IT - Italia 803
CN - Cina 482
SE - Svezia 412
GB - Regno Unito 349
CA - Canada 200
BR - Brasile 174
DE - Germania 124
IN - India 81
FI - Finlandia 39
HK - Hong Kong 33
NL - Olanda 32
JP - Giappone 28
BD - Bangladesh 27
PL - Polonia 24
UA - Ucraina 20
MX - Messico 18
ES - Italia 17
RO - Romania 17
CL - Cile 15
ZA - Sudafrica 15
AU - Australia 14
EU - Europa 12
IR - Iran 12
RU - Federazione Russa 12
CZ - Repubblica Ceca 11
SA - Arabia Saudita 11
VN - Vietnam 8
AT - Austria 7
FR - Francia 7
GR - Grecia 7
IQ - Iraq 7
AE - Emirati Arabi Uniti 6
MA - Marocco 6
NZ - Nuova Zelanda 6
TR - Turchia 6
IE - Irlanda 5
JO - Giordania 5
PK - Pakistan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CH - Svizzera 4
EE - Estonia 4
IL - Israele 4
JM - Giamaica 4
AR - Argentina 3
BB - Barbados 3
DZ - Algeria 3
EG - Egitto 3
KE - Kenya 3
LT - Lituania 3
NO - Norvegia 3
VE - Venezuela 3
BE - Belgio 2
BG - Bulgaria 2
CO - Colombia 2
DK - Danimarca 2
EC - Ecuador 2
HN - Honduras 2
MD - Moldavia 2
MO - Macao, regione amministrativa speciale della Cina 2
MY - Malesia 2
TT - Trinidad e Tobago 2
AL - Albania 1
BN - Brunei Darussalam 1
BO - Bolivia 1
GT - Guatemala 1
HU - Ungheria 1
KW - Kuwait 1
MN - Mongolia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
RS - Serbia 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 11.247
Città #
Chandler 1.195
Singapore 618
Santa Clara 577
Milan 510
Princeton 499
Lawrence 494
Chicago 319
London 297
Wilmington 295
Ottawa 165
Des Moines 152
Ashburn 109
Boardman 88
Munich 86
Shanghai 61
Guangzhou 46
Los Angeles 46
Norwalk 42
Rome 41
Pune 40
Beijing 39
Catanzaro 34
The Dalles 34
Hong Kong 30
Turku 30
New York 29
San Francisco 25
Redmond 23
Redwood City 22
Wuhan 22
São Paulo 21
Brooklyn 20
Naples 20
Tokyo 19
Assago 16
Shenzhen 16
Warsaw 16
Falls Church 15
Atlanta 14
Boston 14
Washington 13
Charlotte 12
Dallas 12
Montreal 12
Stockholm 12
Wuxi 12
Ann Arbor 11
Mexico City 11
Phoenix 11
Rui'an 11
Amsterdam 10
Chennai 10
Columbus 10
Council Bluffs 10
Helsinki 9
Jinan 9
Johannesburg 9
Raleigh 9
Clearwater 8
Dhaka 8
Horia 8
Mountain View 8
Seattle 8
Secaucus 8
West Jordan 8
Hanover 7
Manchester 7
Augusta 6
Brasília 6
Dongyang 6
Jiaxing 6
Las Vegas 6
Olomouc 6
Toronto 6
Viterbo 6
Amman 5
Birmingham 5
Dammam 5
Hefei 5
Madrid 5
Miami 5
Napoli 5
Nuremberg 5
Parenti 5
Rio de Janeiro 5
San Nicola Manfredi 5
Xi'an 5
Andover 4
Curitiba 4
Greensboro 4
Ho Chi Minh City 4
Houston 4
Kingston 4
Nanjing 4
Philadelphia 4
Ponta Grossa 4
Quanzhou 4
Somerset 4
Turin 4
Woodford Green 4
Totale 6.562
Nome #
The 12-week kinetics of anti-SARS-CoV-2 antibodies in different haematological cancers after vaccination with BNT162b2 60
Monitoring of melanoma clinical progression by circulating NK and T cells immunoprofiling: a potential role for CCR7 in metastatic spread 58
Ferritin heavy chain is a negative regulator of ovarian cancer stem cell expansion and epithelial to mesenchymal transition. 55
59. Structural characterization of a biologically active human Lipocortin 1 expressed in Escherichia coli 51
A bipartite activation domain is responsible for the activity of transcription factor HNF1/LFB1 in cells of hepatic and non-hepatic origin 46
A general method to select for M13 clones carrying base pair substitution mutants constructed in vitro 45
The Akt1/IL-6/STAT3 pathway regulates growth of lung tumor initiating cells 45
MicroRNAs regulate resistance to target therapy in melanoma 44
Liver failure and defective hepatocyte regeneration in Interleukin-6 deficient mice 44
A prokaryotic tRNA Tyr gene,inactive in Xenpous Laevis oocytes, is activated by recombination with an eukaryotic tRNA Pro gene 44
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study 43
Mammosphere-forming cells from breast cancer cell lines as a tool for the identification of CSC-like- and early progenitor-targeting drugs 42
A functionally orthogonal estrogen Receptor-based transcription switch Tightly controlled by a non-steroid synthetic ligand 41
Tight control of gene expression by a helper-dependent adenovirus vector carrying the rtTA2s-M2 tetracycline transactivator and repressor system 40
A novel method for site-directed mutagenesis: its application to an eukaryotic tRNAPro gene promoter 40
A fast and sensitive colorimetric assay for IL-6 in hepatoma cells based on the production of a secreted form of alkaline phsphatase (SEAP) 40
A METHODOLOGY FOR SELECTING SUPERAGONISTS, ANTAGONISTS AND SUPERANTAGONISTS OF HORMONES WHOSE RECEPTOR COMPLEX INCLUDES GP 130 40
Analysis of T and Natural Killer cells immune response in Ipilimumab treated 40
DNA sequence of a pseudogene for human C-reactive protein 39
A novel minigene scaffold for therapeutic cancer vaccines 39
Inhibition of Stearoyl-Coa desaturase 1 (SCD1) enzymatic activity reverts BRAFi and MEKi-induced selection of cancer stem cells in BRAF-mutated malignant melanoma 39
ADENOVIRAL VECTORS ENCODING ERYTHROPOIETIN AND THEIR USE IN GENE THERAPY 39
A fast and sensitive colorimetric assay for IL-6 on hepatoma cells based on the production of a secreted form of alkaline phosphatase (SEAP) 38
A novel multi-drug metronomic chemotherapy significantly delays tumor growth in mice 38
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 38
Leptin receptor-mediated regulation of cholinergic neurotransmitter phenotype in cells of central nervous system origin 37
Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma 37
An improved helper-dependent adenoviral vector allows persistent gene expression after i.m. delivery and overcomes pre-existing immunity to adenovirus 37
A novel Chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines 37
PROGRESS AND PROSPECTS: TRANSCRIPTION REGULATORY SYSTEMS 36
Monovalent phage display of human Interleukin (hIL)-6: selection superbinder variants for a complex molecular repertoire in hIL-6 D-Helix 36
Antigen-specificity and DTIC before peptide-vaccination differently shape immune-checkpoint expression pattern, anti-tumor functionality and TCR repertoire in melanoma patients 36
Liver-Specific –Alpha 2 Interferon Gene Expression Results in Protection from Induced Hepatitis 36
miR-579-3p controls melanoma progression and resistance to target therapy 36
Adenovirus-mediated gene transfer of a human IL-6 antagonist 36
Genome-wide analysis of copy number alterations led to the characterisation of PDCD10 as oncogene in ovarian cancer 36
Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth 35
Interleukin-6 receptor antagonists inhibit IL-11 biological activity 35
A novel mouse model for evaluation and prediction of HLA-A2-restricted CEA cancer vaccine responses 35
Deducing the functional characteristics of the human selenoprotein SELK from the structural properties of its intrinsically disordered C-terminal domain 35
Intratumor RNA interference of cell cycle genes slows down tumor progression 35
Two distinct and independent sites on IL-6 trigger gp130 dimer formation and signalling 35
The molecular design of human IL-6 receptor antagonists 34
Combinations of immuno-checkpoint inhibitors predictive biomarkers only marginally improve their individual accuracy 34
T-CELL PEPTIDE EPITOPES FROM CARCINOEMBRYONIC ANTIGEN, IMMUNOGENIC ANALOGS, AND USES THEREOF 34
IL-6 is required for airway mucus production induced by inhaled fungal allergens 33
Epigenetic Changes Induced by Green Tea Catechins are Associated with Prostate Cancer 33
A paradigm shift for erythropoietin: no longer a specialized growth factor, but rather an all-purpose tissue-protective agent 33
A PARADIGM SHIFT FOR ERYTHROPOIETIN: NO LONGER A SPECIALIZED GROWTH FACTOR, BUT RATHER THAN AN ALL-PURPOSE TISSUE-PROTECTIVE AGENT 33
Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer 32
The potential of BRAF-associated non-coding RNA as a therapeutic target in melanoma 32
Kinesin spindle protein SiRNA slows down tumor progression 32
Generation of IL-6 antagonists by substituting residues in helix A 32
A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope 32
A Multimeric Synthetic Combinatorial peptide library. A Multimeric Synthetic Combinatorial peptide library 32
Isolation of Fully Human Antagonistic RON Antibodies Showing Efficient Block of Downstream Signaling and Cell Migration 31
Electro-gene-transfer as a new tool for cancer immunotherapy in animals 31
ANALYSIS OF THE HIV-A GP41 SPECIFIC IMMUNE RESPONSE USING A MULTIPLEXED ANTIBODY DETECTION ASSAY 31
Electro-gene-transfer: a new approach for muscle gene delivery 31
Targeting the cross-talk between Urokinase receptor and Formyl peptide receptor type 1 to prevent invasion and trans-endothelial migration of melanoma cells 31
Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016 31
MicroRNA-driven deregulation of cytokine expression helps development of drug resistance in metastatic melanoma 31
Interleukin 6 deficient mice are protected from bone loss caused by estrogen depletion 31
B4GALT1 Is a New Candidate to Maintain the Stemness of Lung Cancer Stem Cells 31
ALDOC- and ENO2- driven glucose metabolism sustains 3D tumor spheroids growth regardless of nutrient environmental conditions: a multi-omics analysis 30
Quantitative optical imaging of primary tumor organoid metabolism predicts drug response in breast cancer 30
ErbB2 genetic cancer vaccine in nonhuman primates: relevance of single nucleotide polymorphisms 30
Loss of heterozygosity of imprented genes in SV40 t/T antigen-induced hepatocellular carcinomas 30
Elevated levels of Interleukin-6 in unstable Angina 30
Saturation mutagenesis of the human Interleukin 6 receptor binding site: implications for its three-dimensional structure 30
Novel anti-ErbB3 monoclonal antibodies show therapeutic efficacy in xenografted and spontaneous mouse tumors 30
Alliance Against Cancer, the network of Italian cancer centers bridging research and care. 30
Processing of eukaryotic tRNA precursors: secondary structure of the precursor specific sequences affects the rate but not the accuracy of processing reactions 30
CD8+ T CELL TOLERANCE CAN BE BROKEN BY AN ADENOVIRUS VACCINE WHILE CD4+ T CELL TOLERANCE IS BROKEN BY ADDITIONAL CO-ADMINISTRATION OF A TOLL-LIKE RECEPTOR LIGAND 30
Regulated and prolonged expression of mIFN(alpha) in immunocompetent mice mediated by a helper-dependent adenovirus vector. 30
Internal deletions of amino acids 29-42 of human interleukin-6 (IL-6) differentially affect bioactivity and folding 30
Tumor genotype and immune microenvironment in POLE-ultramutated and MSI-hypermutated Endometrial Cancers: New candidates for checkpoint blockade immunotherapy? 30
Mortality trend for liver cancer in a hyperendemic area of hepatitis C virus infection in southern Italy: join-point analysis and comparison with European and Italian data 30
Tumor biobanks in translational medicine 30
Pazopanib in Metastatic Renal Cancer: A "Real-World" Experience at National Cancer Institute "Fondazione G. Pascale" (vol 7, 287, 2016) 30
Phenotype characterization of human melanoma cells resistant to dabrafenib 30
Dossier biotecnologie: Tutte le tecniche gene per gene. 30
Espressione di geni per tRNA in eucarioti 30
Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation 30
Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth 30
miR-579-3p is a novel master regulator of melanoma progression and drug resistance in metastatic melanoma 29
An adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent deltaE1-E2-E3-E4 Ad5 Vectors 29
Synthetic peptide vaccines: The quest to develop peptide vaccines for influenza, HIV and Alzheimer's disease 29
Cell cycle regulation and induction of apoptosis by IL-6 variants on the multiple myeloma cell line XG-1 29
Adenovirus transduction and culture conditions affect the immunogenicity of murine dendritic cells 29
A therapeutic cancer vaccine targeting carcinoembryonic antigen in intestinal carcinomas 29
Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits Non-small Cell Lung Cancer 29
A TLR9 agonist enhances therapeutic effects of telomerase genetic vaccine 29
Synergistic induction of growth arrest and apoptosis of human myeloma cells by the IL-6 super-antagonist Sant7 and Dexamethasone 29
Immunogenicity and therapeutic efficacy of a dual-component genetic cancer vaccine cotargeting carcinoembryonic antigen and HER2/neu in preclinical models. 29
Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure 29
Enhanced inflammatory response to coronary angioplasty in patients with unstable angina 29
Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy 29
La determinazione dell’impronta genetica individuale mediante l’analisi dei minisateliti ipervariabili come nuova indagine per una più precisa diagnosi di paternità. Considerazione generali e presentazione di un caso peritale 29
Monovalent phage display of human Interleukin (hIL)-6: selection of superbinder variants from a complex molecular repertoire in hIL-6 D-helix 29
Totale 3.468
Categoria #
all - tutte 196.286
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 196.286


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021225 15 12 7 7 20 7 45 23 41 26 4 18
2021/20221.332 20 5 9 316 114 27 60 287 119 153 211 11
2022/20233.544 1.002 62 32 348 446 333 1 259 605 201 212 43
2023/20241.420 349 215 129 79 63 380 49 22 16 24 43 51
2024/20254.729 788 408 184 150 173 601 76 197 702 255 303 892
2025/202632 32 0 0 0 0 0 0 0 0 0 0 0
Totale 11.570